Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Agouron presents rhinovirus 3C protease inhibitor as promising clinical candidate

May 5, 1997

Potential HSV-2 vaccine described by Aviron

May 5, 1997

Anti-HIV antisense oligonucleotides from Hybridon evaluated in SCID mice

May 5, 1997

Antisense oligonucleotides for RSV infection

May 5, 1997

Roche describes TK inhibitors for recurrent HSV infection

May 5, 1997

Synthelabo develops alternative to AChE inhibitors for AD

May 5, 1997

Trimeris prepares potent peptide inhibitors of viral fusion

April 30, 1997

Potent inhibitors of HIV-1 and other enveloped viruses reported

April 30, 1997

Dendrimer polyanions with activity against RSV

April 30, 1997

Schering-Plough develops potent farnesyltransferase inhibitor

April 30, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...